InvestorsHub Logo
Followers 12
Posts 1368
Boards Moderated 0
Alias Born 03/12/2020

Re: None

Monday, 11/29/2021 3:40:04 PM

Monday, November 29, 2021 3:40:04 PM

Post# of 44423
https://www.linkedin.com/posts/national-eye-institute-nei_take-the-risk-test-today-activity-6869318779759841281-yK9_


Don’t think for one second that the NIH ain’t watching what CUBT is doing with repurposing Metformin to treat AMD via an eye drop. They directly link diabetes with vision here and suggest a vision test.

And don’t forget the CUBT advisor working on this is….. “Kapil Bharti, Ph.D. from the National Eye Institute (NEI) at the National Institutes of Health (NIH) has joined our Scientific and Clinical Advisory Board. Dr. Bharti is the lead inventor on the U.S. and Worldwide patent applications licensed exclusively to Curative Biotech to repurpose Metformin into an eye drop to treat degenerative eye diseases like macular degeneration, diabetic retinopathy, Stargardt’s disease, and others. He is a world leader in his field, and we look forward to working closely with him as we prepare to move into clinical trials.”